Alphabet's stock surge, driven by its successful integration of AI, has investors weighing whether its current valuation still offers a compelling entry point for long-term growth.
In its latest investor letter, David Einhorn's Greenlight Capital revealed it has sold its stake in HP Inc., redirecting capital towards AI-focused investments it believes offer superior risk-reward profiles amid the tech giant's recent struggles.
We put the AI chatbot to the test, asking if a savvy $1,000 investment in 2015 could have grown to $1 million by 2025. The answer reveals the extreme rarity of such returns in mainstream markets and highlights the stark difference between hindsight and feasible strategy.
David Einhorn's Greenlight Capital has closed its position in insurer Brighthouse Financial following a sale agreement, detailing the move in its latest investor letter. The hedge fund reported solid quarterly returns but continues to trail the broader market.
In a landmark deal, AstraZeneca has licensed a suite of next-generation weight-loss drugs from China's CSPC, aiming to challenge the dominance of Lilly and Novo Nordisk with longer-acting monthly injectables.
A new industry analysis reveals the apparel and textiles sector is falling dangerously behind on its climate commitments, with progress too slow to meet critical international targets.
HSBC has cut its price target for AI infrastructure firm CoreWeave, warning that rising borrowing costs and significant future funding needs could strain the high-flying company's financial runway.
The educational streaming service CuriosityStream Inc. (NASDAQ: CURI) is drawing strong analyst support following robust Q3 2025 results, with a consensus 'Strong Buy' rating and a $6 price target highlighting significant growth potential from its current trading level.
Precious metals continue their historic surge, outpacing the S&P 500 for a third consecutive year. We examine the powerful drivers behind the rally, from industrial demand to monetary policy, and explore how investors can gain exposure through ETFs while navigating the risks.
Envision Energy will supply its high-capacity EN-226 turbines for a 128MW nearshore wind cluster in Vietnam, marking a significant step in the country's Power Development Plan VIII and setting a potential benchmark for regional offshore development.
Despite reporting a 22% surge in Q4 2025 net income to $4.1 billion, global payments giant Mastercard is cutting approximately 1,400 jobs as part of a strategic review, highlighting the complex balance between growth and operational efficiency in the fintech sector.
BEN finalizes a landmark AI licensing framework for Africa and a university wellbeing pilot while bolstering its balance sheet through capital raises and debt conversion, prompting analysts to question if execution is now the priority.
Klarna Group faces a dual challenge: surging commercial demand for its 'buy now, pay later' services and intensifying legal scrutiny over alleged IPO disclosure failures regarding credit risk. The stock's sharp decline shifts investor focus to upcoming quarterly results and credit quality metrics.
Amazon is reportedly negotiating a landmark investment of up to $50 billion in OpenAI, a move that would reshape the AI landscape and intensify its cloud rivalry with Microsoft and Google. The potential deal highlights the soaring costs of competing in generative AI and could redefine Amazon Web Services' strategy.
The new campus in McBee, SC, aims to bolster North American supply chains for critical minerals, starting with a 2,000-ton annual processing capacity for magnet scrap.
Abigail Fisher, a seasoned HR leader with two decades of experience, is set to rejoin Grant Thornton UK in late February as its inaugural Chief People Officer, signaling a renewed focus on culture and talent.
The $7.6 billion RIA has expanded its internal equity plan to 29 employee-owners, formalizing a decade-long succession strategy that aims to preserve independence as co-founder Barry Ritholtz nears 65.
Building significant wealth often hinges on consistency over brilliance. We examine the Vanguard Growth ETF (VUG), its historical performance, and the disciplined, long-term strategy that could potentially transform regular savings into a seven-figure nest egg.
Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.
Exclusive: A newly revealed State Department cable directs embassies worldwide to audit all assistance programs against stringent new rules prohibiting funding for groups involved in abortion services, diversity initiatives, and gender identity advocacy, expanding a long-contested policy to nearly $30 billion in foreign aid.
